Details for New Drug Application (NDA): 018202
✉ Email this page to a colleague
The generic ingredient in CYTADREN is aminoglutethimide. Additional details are available on the aminoglutethimide profile page.
Summary for 018202
Tradename: | CYTADREN |
Applicant: | Novartis |
Ingredient: | aminoglutethimide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 018202
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018202
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | CYTADREN | aminoglutethimide | TABLET;ORAL | 018202-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | CYTADREN | aminoglutethimide | TABLET;ORAL | 018202-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription